Concepedia

E. Eigendorff

EE

Statistics

Publications

8

Citations

1.5K

H-Index

8

Active since

2002

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Kanagawa Prefectural Hospital Organization

Hôpital d'Instruction des Armées Sainte-Anne

Kanagawa Cancer Center

National Cancer Center Hospital East

E. Eigendorff is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, radiation oncology, and oncology.

Top concepts

Publications per year

2002–2024

8

Publications

8

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

Heather A. Wakelee, Moïshe Liberman, Terufumi Kato et al. · New England Journal of Medicine · 2023 · 903 citations · Full text

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

Jonathan Spicer, Marina Chiara Garassino, Heather A. Wakelee et al. · The Lancet · 2024 · 173 citations · Full text

, , +8

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 152 citations · Full text

, , +7

11β-Hydroxysteroid Dehydrogenase Types 1 and 2: An Important Pharmacokinetic Determinant for the Activity of Synthetic Mineralo- and Glucocorticoids

Sven Diederich, E. Eigendorff, Patrick Burkhardt et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 148 citations · Full text

LBA56 Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC)

J.D. Spicer, Shugeng Gao, Moïshe Liberman et al. · Annals of Oncology · 2023 · 70 citations · Full text

, , +7

1–5 of 8